News

The ALLG welcomes the release of the Australian National AML Clinical Guidelines. These guidelines have been developed with the leadership and expert input of ALLG member Professor Andrew Wei in collaboration with the National Blood Cancer Taskforce and the Haematology Society of Australia and New Zealand (HSANZ).

We are excited to share this invaluable resource with the Australian haematology community and strongly encourage all healthcare professionals and researchers involved in the diagnosis, treatment, and management of AML to utilise these guidelines in their practice.

 

Why the AML Clinical Guidelines are Important

Acute Myeloid Leukaemia (AML) is a complex and aggressive blood cancer requiring precise, evidence-based management. The new AML Clinical Guidelines aim to streamline clinical decision-making and enhance patient outcomes by providing expert-driven, evidence-based treatment recommendations. With a focus on improving the quality of care for AML patients, these guidelines offer clear, structured guidance for haematologists, researchers, and healthcare teams involved in diagnosing, treating, and managing AML.

 

Key Objectives of the AML Clinical Guidelines

The AML Guidelines aim to:

Improve Patient Outcomes – Standardised, evidence-based recommendations for optimal care

Support Clinical Decisions – Practical, evidence-based treatment pathways

Enhance Consistency in Care – Reducing unwarranted variations in care

 

What the AML Clinical Guidelines Offer

These guidelines provide a comprehensive framework covering key aspects of AML management, including:

Clear Treatment Pathways – Step-by-step guidance for AML diagnosis, risk stratification, and treatment

Pharmaceutical Strategies – Evidence-backed recommendations on induction, consolidation, and maintenance therapy

 

Antimicrobial Prophylaxis – Expert-driven strategies for infection prevention and management.

Emerging Therapies & Access – Insights into newly approved drugs, novel agents, and accessibility

 

Improving AML Care in Australia

By adopting these clinical guidelines, healthcare professionals can contribute to a more effective and patient-centric approach to AML treatment. ALLG supports the role of the AML Clinical Guidelines in ensuring evidence-driven treatment recommendations, which is aligned to ALLG’s commitment to Better treatments…Better lives.

 Access the Guidelines here: hsanz.org.au/AML-Guidelines